Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2024

For the six-months ended June 30, 2024, Legend Biotech expects to record an adjusted net loss for the period of approximately $94.7 million to $109.7 million. See "Use of Non-IFRS Financial Measures" below for a reconciliation of net loss to adjusted net loss for the first six months of the year. Use of Non-IFRS Financial Measures The following table provides a reconciliation of Legend Biotech's net loss for the six-month period to adjusted net loss for the six-month period: About Legend Biotech Learn more ...